Report cover image

Global Liver Cirrhosis Market Analysis and Forecast 2025-2031

Publisher APO Research, Inc.
Published Oct 20, 2025
Length 194 Pages
SKU # APRC20561303

Description

Summary

According to APO Research, The global Liver Cirrhosis market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The North America market for Liver Cirrhosis is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Liver Cirrhosis is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The China market for Liver Cirrhosis is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Liver Cirrhosis is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of Liver Cirrhosis include Johnson & Johnson, Merck, GlaxoSmithKline, Bristol-Myers Squibb, Intercept Pharmaceuticals, Instituto Grifols, Gwo Xi Stem Cell Applied Technology, Gilead Sciences and F Hoffman La-Roche, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Includes


This report presents an overview of global market for Liver Cirrhosis, market size. Analyses of the global market trends, with historic market revenue data for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Liver Cirrhosis, also provides the revenue of main regions and countries. Of the upcoming market potential for Liver Cirrhosis, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Liver Cirrhosis revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Liver Cirrhosis market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2020 to 2031. Evaluation and forecast the market size for Liver Cirrhosis revenue, projected growth trends, production technology, application and end-user industry.

Liver Cirrhosis Segment by Company

Johnson & Johnson
Merck
GlaxoSmithKline
Bristol-Myers Squibb
Intercept Pharmaceuticals
Instituto Grifols
Gwo Xi Stem Cell Applied Technology
Gilead Sciences
F Hoffman La-Roche
Conatus Pharmaceuticals
Liver Cirrhosis Segment by Type

Cryptogenic Cirrhosis
Cardiac Cirrhosis
Atrophic Cirrhosis
Alcoholic Cirrhosis
Biliary Cirrhosis
Liver Cirrhosis Segment by Application

Hospitals
Specialty Clinics
Liver Cirrhosis Segment by Region

North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Liver Cirrhosis market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Liver Cirrhosis and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Liver Cirrhosis.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of Liver Cirrhosis in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Liver Cirrhosis company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Liver Cirrhosis revenue, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.

Table of Contents

194 Pages
1 Market Overview
1.1 Product Definition
1.2 Liver Cirrhosis Market by Type
1.2.1 Global Liver Cirrhosis Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Cryptogenic Cirrhosis
1.2.3 Cardiac Cirrhosis
1.2.4 Atrophic Cirrhosis
1.2.5 Alcoholic Cirrhosis
1.2.6 Biliary Cirrhosis
1.3 Liver Cirrhosis Market by Application
1.3.1 Global Liver Cirrhosis Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Hospitals
1.3.3 Specialty Clinics
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 Liver Cirrhosis Market Dynamics
2.1 Liver Cirrhosis Industry Trends
2.2 Liver Cirrhosis Industry Drivers
2.3 Liver Cirrhosis Industry Opportunities and Challenges
2.4 Liver Cirrhosis Industry Restraints
3 Global Growth Perspective
3.1 Global Liver Cirrhosis Market Perspective (2020-2031)
3.2 Global Liver Cirrhosis Growth Trends by Region
3.2.1 Global Liver Cirrhosis Market Size by Region: 2020 VS 2024 VS 2031
3.2.2 Global Liver Cirrhosis Market Size by Region (2020-2025)
3.2.3 Global Liver Cirrhosis Market Size by Region (2026-2031)
4 Competitive Landscape by Players
4.1 Global Liver Cirrhosis Revenue by Players
4.1.1 Global Liver Cirrhosis Revenue by Players (2020-2025)
4.1.2 Global Liver Cirrhosis Revenue Market Share by Players (2020-2025)
4.1.3 Global Liver Cirrhosis Players Revenue Share Top 10 and Top 5 in 2024
4.2 Global Liver Cirrhosis Key Players Ranking, 2023 VS 2024 VS 2025
4.3 Global Liver Cirrhosis Key Players Headquarters & Area Served
4.4 Global Liver Cirrhosis Players, Product Type & Application
4.5 Global Liver Cirrhosis Players Establishment Date
4.6 Market Competitive Analysis
4.6.1 Global Liver Cirrhosis Market CR5 and HHI
4.6.3 2024 Liver Cirrhosis Tier 1, Tier 2, and Tier 3
5 Liver Cirrhosis Market Size by Type
5.1 Global Liver Cirrhosis Revenue by Type (2020 VS 2024 VS 2031)
5.2 Global Liver Cirrhosis Revenue by Type (2020-2031)
5.3 Global Liver Cirrhosis Revenue Market Share by Type (2020-2031)
6 Liver Cirrhosis Market Size by Application
6.1 Global Liver Cirrhosis Revenue by Application (2020 VS 2024 VS 2031)
6.2 Global Liver Cirrhosis Revenue by Application (2020-2031)
6.3 Global Liver Cirrhosis Revenue Market Share by Application (2020-2031)
7 Company Profiles
7.1 Johnson & Johnson
7.1.1 Johnson & Johnson Comapny Information
7.1.2 Johnson & Johnson Business Overview
7.1.3 Johnson & Johnson Liver Cirrhosis Revenue and Gross Margin (2020-2025)
7.1.4 Johnson & Johnson Liver Cirrhosis Product Portfolio
7.1.5 Johnson & Johnson Recent Developments
7.2 Merck
7.2.1 Merck Comapny Information
7.2.2 Merck Business Overview
7.2.3 Merck Liver Cirrhosis Revenue and Gross Margin (2020-2025)
7.2.4 Merck Liver Cirrhosis Product Portfolio
7.2.5 Merck Recent Developments
7.3 GlaxoSmithKline
7.3.1 GlaxoSmithKline Comapny Information
7.3.2 GlaxoSmithKline Business Overview
7.3.3 GlaxoSmithKline Liver Cirrhosis Revenue and Gross Margin (2020-2025)
7.3.4 GlaxoSmithKline Liver Cirrhosis Product Portfolio
7.3.5 GlaxoSmithKline Recent Developments
7.4 Bristol-Myers Squibb
7.4.1 Bristol-Myers Squibb Comapny Information
7.4.2 Bristol-Myers Squibb Business Overview
7.4.3 Bristol-Myers Squibb Liver Cirrhosis Revenue and Gross Margin (2020-2025)
7.4.4 Bristol-Myers Squibb Liver Cirrhosis Product Portfolio
7.4.5 Bristol-Myers Squibb Recent Developments
7.5 Intercept Pharmaceuticals
7.5.1 Intercept Pharmaceuticals Comapny Information
7.5.2 Intercept Pharmaceuticals Business Overview
7.5.3 Intercept Pharmaceuticals Liver Cirrhosis Revenue and Gross Margin (2020-2025)
7.5.4 Intercept Pharmaceuticals Liver Cirrhosis Product Portfolio
7.5.5 Intercept Pharmaceuticals Recent Developments
7.6 Instituto Grifols
7.6.1 Instituto Grifols Comapny Information
7.6.2 Instituto Grifols Business Overview
7.6.3 Instituto Grifols Liver Cirrhosis Revenue and Gross Margin (2020-2025)
7.6.4 Instituto Grifols Liver Cirrhosis Product Portfolio
7.6.5 Instituto Grifols Recent Developments
7.7 Gwo Xi Stem Cell Applied Technology
7.7.1 Gwo Xi Stem Cell Applied Technology Comapny Information
7.7.2 Gwo Xi Stem Cell Applied Technology Business Overview
7.7.3 Gwo Xi Stem Cell Applied Technology Liver Cirrhosis Revenue and Gross Margin (2020-2025)
7.7.4 Gwo Xi Stem Cell Applied Technology Liver Cirrhosis Product Portfolio
7.7.5 Gwo Xi Stem Cell Applied Technology Recent Developments
7.8 Gilead Sciences
7.8.1 Gilead Sciences Comapny Information
7.8.2 Gilead Sciences Business Overview
7.8.3 Gilead Sciences Liver Cirrhosis Revenue and Gross Margin (2020-2025)
7.8.4 Gilead Sciences Liver Cirrhosis Product Portfolio
7.8.5 Gilead Sciences Recent Developments
7.9 F Hoffman La-Roche
7.9.1 F Hoffman La-Roche Comapny Information
7.9.2 F Hoffman La-Roche Business Overview
7.9.3 F Hoffman La-Roche Liver Cirrhosis Revenue and Gross Margin (2020-2025)
7.9.4 F Hoffman La-Roche Liver Cirrhosis Product Portfolio
7.9.5 F Hoffman La-Roche Recent Developments
7.10 Conatus Pharmaceuticals
7.10.1 Conatus Pharmaceuticals Comapny Information
7.10.2 Conatus Pharmaceuticals Business Overview
7.10.3 Conatus Pharmaceuticals Liver Cirrhosis Revenue and Gross Margin (2020-2025)
7.10.4 Conatus Pharmaceuticals Liver Cirrhosis Product Portfolio
7.10.5 Conatus Pharmaceuticals Recent Developments
8 North America
8.1 North America Liver Cirrhosis Revenue (2020-2031)
8.2 North America Liver Cirrhosis Revenue by Type (2020-2031)
8.2.1 North America Liver Cirrhosis Revenue by Type (2020-2025)
8.2.2 North America Liver Cirrhosis Revenue by Type (2026-2031)
8.3 North America Liver Cirrhosis Revenue Share by Type (2020-2031)
8.4 North America Liver Cirrhosis Revenue by Application (2020-2031)
8.4.1 North America Liver Cirrhosis Revenue by Application (2020-2025)
8.4.2 North America Liver Cirrhosis Revenue by Application (2026-2031)
8.5 North America Liver Cirrhosis Revenue Share by Application (2020-2031)
8.6 North America Liver Cirrhosis Revenue by Country
8.6.1 North America Liver Cirrhosis Revenue by Country (2020 VS 2024 VS 2031)
8.6.2 North America Liver Cirrhosis Revenue by Country (2020-2025)
8.6.3 North America Liver Cirrhosis Revenue by Country (2026-2031)
8.6.4 United States
8.6.5 Canada
9 Europe
9.1 Europe Liver Cirrhosis Revenue (2020-2031)
9.2 Europe Liver Cirrhosis Revenue by Type (2020-2031)
9.2.1 Europe Liver Cirrhosis Revenue by Type (2020-2025)
9.2.2 Europe Liver Cirrhosis Revenue by Type (2026-2031)
9.3 Europe Liver Cirrhosis Revenue Share by Type (2020-2031)
9.4 Europe Liver Cirrhosis Revenue by Application (2020-2031)
9.4.1 Europe Liver Cirrhosis Revenue by Application (2020-2025)
9.4.2 Europe Liver Cirrhosis Revenue by Application (2026-2031)
9.5 Europe Liver Cirrhosis Revenue Share by Application (2020-2031)
9.6 Europe Liver Cirrhosis Revenue by Country
9.6.1 Europe Liver Cirrhosis Revenue by Country (2020 VS 2024 VS 2031)
9.6.2 Europe Liver Cirrhosis Revenue by Country (2020-2025)
9.6.3 Europe Liver Cirrhosis Revenue by Country (2026-2031)
9.6.4 Germany
9.6.5 France
9.6.6 U.K.
9.6.7 Italy
9.6.8 Netherlands
10 China
10.1 China Liver Cirrhosis Revenue (2020-2031)
10.2 China Liver Cirrhosis Revenue by Type (2020-2031)
10.2.1 China Liver Cirrhosis Revenue by Type (2020-2025)
10.2.2 China Liver Cirrhosis Revenue by Type (2026-2031)
10.3 China Liver Cirrhosis Revenue Share by Type (2020-2031)
10.4 China Liver Cirrhosis Revenue by Application (2020-2031)
10.4.1 China Liver Cirrhosis Revenue by Application (2020-2025)
10.4.2 China Liver Cirrhosis Revenue by Application (2026-2031)
10.5 China Liver Cirrhosis Revenue Share by Application (2020-2031)
11 Asia (Excluding China)
11.1 Asia Liver Cirrhosis Revenue (2020-2031)
11.2 Asia Liver Cirrhosis Revenue by Type (2020-2031)
11.2.1 Asia Liver Cirrhosis Revenue by Type (2020-2025)
11.2.2 Asia Liver Cirrhosis Revenue by Type (2026-2031)
11.3 Asia Liver Cirrhosis Revenue Share by Type (2020-2031)
11.4 Asia Liver Cirrhosis Revenue by Application (2020-2031)
11.4.1 Asia Liver Cirrhosis Revenue by Application (2020-2025)
11.4.2 Asia Liver Cirrhosis Revenue by Application (2026-2031)
11.5 Asia Liver Cirrhosis Revenue Share by Application (2020-2031)
11.6 Asia Liver Cirrhosis Revenue by Country
11.6.1 Asia Liver Cirrhosis Revenue by Country (2020 VS 2024 VS 2031)
11.6.2 Asia Liver Cirrhosis Revenue by Country (2020-2025)
11.6.3 Asia Liver Cirrhosis Revenue by Country (2026-2031)
11.6.4 Japan
11.6.5 South Korea
11.6.6 India
11.6.7 Australia
11.6.8 Taiwan
11.6.9 Southeast Asia
12 South America, Middle East and Africa
12.1 SAMEA Liver Cirrhosis Revenue (2020-2031)
12.2 SAMEA Liver Cirrhosis Revenue by Type (2020-2031)
12.2.1 SAMEA Liver Cirrhosis Revenue by Type (2020-2025)
12.2.2 SAMEA Liver Cirrhosis Revenue by Type (2026-2031)
12.3 SAMEA Liver Cirrhosis Revenue Share by Type (2020-2031)
12.4 SAMEA Liver Cirrhosis Revenue by Application (2020-2031)
12.4.1 SAMEA Liver Cirrhosis Revenue by Application (2020-2025)
12.4.2 SAMEA Liver Cirrhosis Revenue by Application (2026-2031)
12.5 SAMEA Liver Cirrhosis Revenue Share by Application (2020-2031)
12.6 SAMEA Liver Cirrhosis Revenue by Country
12.6.1 SAMEA Liver Cirrhosis Revenue by Country (2020 VS 2024 VS 2031)
12.6.2 SAMEA Liver Cirrhosis Revenue by Country (2020-2025)
12.6.3 SAMEA Liver Cirrhosis Revenue by Country (2026-2031)
12.6.4 Brazil
12.6.5 Argentina
12.6.6 Chile
12.6.7 Colombia
12.6.8 Peru
12.6.9 Saudi Arabia
12.6.10 Israel
12.6.11 UAE
12.6.12 Turkey
12.6.13 Iran
12.6.14 Egypt
13 Concluding Insights
14 Appendix
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer
How Do Licenses Work?
Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.